Nov 29, 2022 / 03:30PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Okay. Thanks, everyone, for joining us this morning. It's a pleasure to have with us Thermo Fisher. We have CEO and Chairman, Marc Casper. I think in the background, we have Eileen Pattinson and Rafael Tejada from the Investor Relations team. It's been a fascinating, fascinating year for life science companies, and I think Thermo embodifies why life sciences as an industry stands out in health care. It's really -- in a key, it's organic, right? Impressive.
But maybe Marc, I think I'll let you kick start with a few opening remarks and then we can get into the Q&A. But thank you for taking the time this morning.
Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO
So Vijay, it's great to see you. Thanks for having us at the conference as we get to the final parts of 2022. And when I think about the year, obviously, we have some work to do yet to
Thermo Fisher Scientific Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers